Physician profile
David M Ostrick
NPI 1831114073
$4,664.93
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,057 · 2020: $34.77 · 2021: $231 · 2022: $283 · 2023: $58.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $3,924.01 | 2019 | |
| Glaukos Corporation | $197.77 | 2019-2023 | |
| Rxsight INC | $132.82 | 2022 | |
| Horizon Therapeutics Plc | $122.99 | 2022 | |
| Kala Pharmaceuticals, INC. | $121.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.43 | 2019 | |
| Sun Pharmaceutical Industries INC. | $29.34 | 2023 | Cequa |
| Abbvie INC. | $27.32 | 2022 | |
| Alimera Sciences, INC. | $22.64 | 2019 | |
| Eyevance Pharmaceuticals LLC | $18.72 | 2020 | |
| Allergan, INC. | $16.32 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ostrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.